DARPA has revealed the three teams that will work under its Hearnessing Enzymatic Activity for Lifesaving Remedies (HEALR) program to help d...
DARPA has revealed the three teams that will work under its Hearnessing Enzymatic Activity for Lifesaving Remedies (HEALR) program to help develop new medical technologies targeted at “emerging microbial threats.” DARPA seems to be particularly interested in addressing ‘superbugs,’ which refers to bacteria that is resistant to multiple different drugs typically used to treat infections. DARPA’s HEALR program is designed … Continue readingfrom SlashGear https://ift.tt/3CnS5Ea
via IFTTT

COMMENTS